What is the HCP Clinic Portal?
The HCP Clinic Portal was developed for use in the clinic with your MAVENCLAD® advevaTM PSP patients. It's a patient management platform - a simple tool to help you better manage your patients' care plans and their progress on MAVENCLAD®.
The HCP Clinic Portal provides you with information about your patient's MAVENCLAD® treatment at different stages within their treatment cycle. There's also a dashboard that gives you an overview of your caseload as well as a guide to recommend tests and treatments for the patient.
You will need to register as a Physician/Nurse on your first visit to the Portal.
Watch the video to see step-by-step instructions
Terms of use
Should you disagree with these conditions, we must ask you not to use this website. By using this website, you declare that you are using the website and its content at your own risk.
Thank you for your interest in the adveva™ for people prescribed MAVENCLAD® patient support programme (the “Programme”) offered through www.mavencladadveva.com.au (“Website”).
Merck Healthcare Pty Ltd (Merck) have directed a third party service provider, hired by Merck (1) manage the MAVENCLAD® adveva™️ patient support programme (2) to collect and use your personal information to register you for the programme and (3) to provide you with the services and features offered as part of the programme, which may include print or online publications, telephone and email messages depending on what you have elected to receive during the registration process. Merck and its service providers comply with all legal requirements of Australia concerning privacy including the Privacy Act 1988 (Cth) (the “Privacy Act”) and the Australian Privacy Principles (“APPs”).
This Website is owned and operated by Merck. Access to and use of this Website is subject to the following Terms and Conditions (“Terms”). Should you disagree with these Terms, we must ask you not to use this Website. By using this Website, you declare that you are using the Website and its content at your own risk and that you agree to be bound by these Terms.
Access
Access to different functionalities on the Website will vary depending on category of user:
(a) Healthcare Professionals (“HCP”)
HCP access includes the following functionality:
- access to information on multiple sclerosis and Merck products, including downloads of information and educational materials for patients and HCPs;
(b) Patient access includes the following functionality:
- access to information regarding multiple sclerosis and MAVENCLAD® including educational and instructional materials;
Exclusion and Limitation of Liability
The content, products and services available on this Website are provided on an “as is” basis. Merck does not represent that the information contained in this Website is accurate, comprehensive, verified, complete or error free.
To the maximum extent permitted by law, Merck excludes all liability whether in contract or in tort (including negligence), as to the compatibility, security, quality or fitness for purpose of any content or any goods or services available on this Website. Merck assumes no liability for the contents of any other website you may access from this Website.
Merck will not be liable for any losses sustained and arising out of or in connection with use of this Website including, without limitation, indirect or consequential losses, loss of profit, loss of goodwill, loss of data or special loss. If any law prohibits the exclusion of such liability, Merck limits its liability to the extent permitted by law, to the resupply of the relevant material or information.
Intellectual Property Rights
All intellectual property rights of any kind in this Website is owned by or licensed to Merck and is protected by copyright, trademark and other intellectual property rights and laws. All rights to the Website or arising from the same shall remain with Merck.
Merck grants to you a limited licence to access the Website including any documents, presentations and content contained in it for the purposes set out in these Terms.
Merck may modify this Website and/or discontinue its operation at any time without prior announcement, either wholly or in part, at its own discretion and without accepting liability. Merck is under no obligation to update the content of this Website.
Unless otherwise indicated in these Terms, all details, documents and presentations published on this Website are owned by Merck. Unless written consent has been obtained from Merck (Corporate Communications Department), no permission is given to import published and copyrighted content from our Website to other programmes or Websites or to use such content in any other way.
Unless otherwise provided in these Terms, nothing in these Terms shall be construed as conferring on you any right or licence (by implication, estoppel or otherwise), under copyright or other intellectual property rights, in relation to the Website and content on the Website. Apart from fair dealing for the purpose of personal use, private study, research, criticism or review as permitted under copyright legislation, you may not reproduce, transmit, adapt, distribute, sell, modify or publish or otherwise use any of the material on this Website without Merck prior written consent.
International users must also observe any special provisions under local legislation relevant to this Website and the subject matter of these Terms.
Personal Information
Merck is particularly concerned to ensure the protection of your personal information as defined in the Privacy Act 1988 (Cth) and the Australian Privacy Principles. You will find information on the collection, use and disclosure of personal information in the Privacy Policy and Privacy Statement available on this Website.
The information provided as a consequence of your participation in the Programme does not replace the information and advice provided by a medical practitioner and in the event of any emergency, you should contact your healthcare professional. Your discussions with the Merck personnel may also be provided to your healthcare professional (provided you have given your consent), otherwise the service provider will not disclose your personal information unless required or permitted by law. Merck and its service providers may also use your personal information to follow up on adverse events, for market research purposes and to contact you to provide support and education as part the Programme which may include post, email and telephone communications.
You may withdraw from the programme, access or update your personal information at any time by contacting the Programme coordinator on 1800 290 895.
Prohibited Use
You must only use the Website in accordance with these Terms. You must not do or fail to do, directly or indirectly, anything which may:
- violate any applicable local, state, national or international laws;
- infringe or adversely affect our right, title, and interest in the Website or content of the Website;
- infringe or adversely affect any third party’s rights;
- interfere with or disrupt the Website’s operation, functionality, security or any hardware, software, servers, networks or equipment connected to it;
- interfere with or disrupt the use of the Website by other users of the Website;
- “stalk” or otherwise harass other users of the Website;
- attempt to monitor, gather or extract information about Website usage, architecture or users; or
- create a link to any part of the Website without our prior written consent.
This is a secure access website. You must not, without Merck’s prior written consent, modify, reproduce, adapt, alter, decompile, disassemble, reverse engineer, post or upload to another website, transmit, broadcast, copy, duplicate, distribute, publish, create derivative works of, exploit or otherwise deal with any material on the Website in any way, in whole or in part.
If in the reasonable opinion of Merck you fail to comply with any of these Terms, we may terminate or limit your access to this Website.
Information and materials you provide to Merck
Subject to our Privacy Policy, if you provide us with any ideas, suggestions, information or other material on this Website in relation to Merck, our services or this Website, you agree that we may use, reproduce, publish, modify, adapt and transmit them to others free of charge and without restriction.
You must not post or transmit any material on the Website that you do not have the right to post or transmit, for example, under intellectual property, confidentiality, privacy or other applicable laws.
You must not post any material on the Website without providing proper attribution to its original author or copyright owner or without the original owner or copyright owner’s consent.
You must not post or transmit on the Website:
- unsolicited or unauthorised content, including advertising or promotional materials;
- content that contains software viruses or any other computer code, files or programmes designed to interrupt, destroy or limit the functionality of the Website; or
- content that is harmful, obscene, offensive, abusive, invasion of privacy, defamatory, hateful, illegal or otherwise discriminatory.
Links
This Website may contain links to other websites which are not under Merck control or which are not maintained by Merck.
The links to any such third party websites are provided for your convenience and information only. If you access these websites you do so at your own risk.
Merck is not responsible for the content of those websites and will not be liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use or your reliance on any such content.
The fact that a website is linked to this Website does not imply any endorsement or sponsorship by us of that website or that Merck is affiliated in any way with the third party operating that third party website.
Third Party Content, Products and Services
Products and services offered for sale or advertised, and other information found on this Website may be the products, services, and information of third parties. Third party products and services are not provided by Merck. If you purchase third party products and services, your legal relationship will be with the third party supplier and not Merck. You must check with any third party supplier as to the terms of provision of such products and services and the costs and charges involved. Merck may receive fees or commissions from third parties for such products and services.
Effect on our Terms and Conditions of Sale
Unless express otherwise specified in writing, the Terms and Conditions of Sale of Merck are not affected by the Website, it’s content, material or details.
Programme Information / Privacy and Consent
MAVENCLAD® adveva™ Patient Support Programme (PSP)
Product PSP information & Privacy Consent – about this programme
This is a patient support programme administered by Merck Healthcare Pty Ltd (“Merck”) and is intended only for patients prescribed MAVENCLAD® – Registered trademark in Australia or New Zealand (ANZ).
The programme aims to provide support to patients prescribed MAVENCLAD® by way of general advice and reminders to assist with their treatment and monitoring. The specific support available depends on the treatment you have been prescribed and the programme you are enrolled in.
All advice is of a general nature to support the prescribing instructions of your doctor and is never intended to replace advice or instructions provided by your prescribing doctor or healthcare team. You should contact your doctor for specific advice about your treatment or in the case of immediate or urgent advice.
Your treatment details will be shared with your treating Doctor to assist them in managing your care on MAVENCLAD®.
Participation is entirely voluntary, and you can withdraw anytime simply by contacting the programme on the nominated phone number/email.
Privacy, collection of information and consent information you should be aware of
It is strongly recommended that you read and understand Merck’s full privacy statement for this programme. To be enrolled in this support programme we shall require that you acknowledge that you are prescribed the product, that you have read and understood the information about the programme and the privacy/collection statement and that you provide your consent to Merck to be enrolled as a member of the programme. This patient support programme is operated by personnel within Merck’s Medical Services Information department. Depending on your programme specifics, you may be contacted by someone from Merck’s Medical Services Information by phone, mail, email or SMS.
By providing your personal information to Merck and continuing to engage with Merck via this programme you are providing your consent to the personal information you provide being collected, used and stored as described in the full Merck privacy statement (link below).
We only collect information that is required to assess your eligibility and to provide assistance and services within this support programme. This includes (but is not limited to) information such as your name, address, date of birth, past treatments (if any), details of the Merck treatment (e.g. dose, frequency etc) and your prescribing doctors name and clinic address.
In the instance of changes to the programme or product or an adverse event being reported while enrolled in the MAVENCLAD® Patient Support Programme, Merck, or an authorised third party may contact you for follow-up or may contact your doctor to obtain more detailed information in some cases.
The MAVENCLAD® Patient Support Programme will notify your Doctor that they have a patient enrolled in the programme and if requested share your treatment details from the programme with them to assist in the management of your appointments and care on MAVENCLAD®.
Your personal information is only provided/accessible to those that need it to fulfil some aspect of the service which you have consented to such as the mandatory reporting of side effects or other safety issues you advise us of; or programme/system maintenance. This sometimes includes 3rd party service providers who assist Merck with the programme, but only the minimum relevant information needed is provided. All persons with access to your personal information are bound by the Merck privacy statement.
Anonymised data and information may be used by Merck or its affiliates – this includes any member of the Merck Group to evaluate and improve the programme and may be published in a medical journal. The reports or abstracts will not identify any individual patient or identify anyone from your healthcare team, the data will be anonymised.
All information collected from you is kept on secure, password-controlled servers in Australia and New Zealand (ANZ) and outside of ANZ in countries that have similar privacy laws/regulations and expectations as in ANZ. At all times, adherence to the Australian and New Zealand (ANZ) Privacy Principles will be maintained.
For more details about how Merck handles your personal/sensitive information, the use of “cookies” or Google analytics; please refer to the Merck privacy statement (link below).
You can withdraw your consent or alter your preferences at any time simply by advising us.
Phone: AUSTRALIA 1800 290 895 NEW ZEALAND 0800 426 252
Hours: 9.00am to 5.00pm (AEST)
Email: mavencladadveva@merckgroup.com
Link to Merck privacy statement:
https://www.merckgroup.com/en/privacy-statement.html
More information:
If you have any questions or comments, please feel free to contact the Privacy Officer at Merck Healthcare (Australia) via the above contact details.
Merck Healthcare Pty Ltd | ABN 72 006 900 830 | Suite 1, Level 1, Building B, 11 Talavera Road, Macquarie Park, NSW 2113 Australia
Phone: 1800 257 348
Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Auckland 2022
Phone (NZ) 0800 426 252
Date of preparation: July 2021 | AU-NONNI-00009
Date of revision: 30 July 2021
Programme Information / Privacy and Consent
MAVENCLAD® adveva™ Patient Support Programme (PSP)
You are about to register as a Healthcare Professional (HCP) on the adveva™ for MAVENCLAD® website (the Site). This website forms part of a Patient Support Programme (the Programme) administered by Merck Healthcare Pty Ltd (“Merck”) and is intended only for patients prescribed MAVENCLAD® and their treating HCP’s.
You will be required to provide your name and email address and APHRA number for validation purposes. Merck will collect the personal information that you provide when logging into this Site. This is used by Merck to: ensure you are a registered HCP, to register a patient into the Programme and to monitor your visits to the site.
Merck will not provide your personal details to third parties except where that party is providing a service on behalf of Merck and has agreed to comply with the Merck Privacy Policy, which can be accessed at www.merck.com.au
Merck will take all steps reasonably necessary to ensure that the personal information you provide is adequately protected according to the requirements of applicable data protection laws. All information collected from you is kept on secure, password-controlled servers in Australia and New Zealand (ANZ) and outside of ANZ in countries that have similar privacy laws/regulations and expectations as in ANZ. At all times, adherence to the Australian and New Zealand (ANZ) Privacy Principles will be maintained.
Deidentified and aggregated (i.e. pooled) information may be used by Merck to evaluate and improve the programme and may be published in a medical journal. The reports or abstracts will not identify you, any individual patient or identify anyone from your healthcare team.
From time to time, Merck may contact you for feedback on the programme and services provided by Merck. In such instances, your feedback will be voluntary.
For more details about how Merck handles your personal/sensitive information, the use of “cookies” or Google analytics; please refer to the Merck privacy statement (link below).
You have the right to withdraw your consent to the use of your personal information at any time by contacting the Privacy Officer at Merck Healthcare (Australia) via:
Phone: AUSTRALIA 1800 290 895
Hours: 9.00am to 5.00pm (AEST)
Email: mavencladadveva@merckgroup.com
Link to Merck privacy statement:
https://www.merckgroup.com/en/privacy-statement.html
By ticking “I accept” you acknowledge that you are a registered HCP and that you have read and understood the information above.